- Physician's Weekly

Shaping First-Line Therapy Decisions in PsA

Jun 17, 2025

Soumya Chakravarty, MD, PhD, FACP, FACR, senior director, strategic lead rheumatology therapeutic area, Johnson & Johnson Innovative Medicine, highlights the APEX study’s findings that Tremfya (guselkumab) is the first IL-23 inhibitor to significantly inhibit structural damage progression in biologic-naïve psoriatic arthritis patients, offering a multi-domain, early treatment option with a consistent safety profile to help preserve long-term function and quality of life.

World Blood Donor Day 2025 Arrives as Summer Blood Supplies Often Run Low

Jun 14, 2025

Physician’s Weekly spoke with Amanda Hess, vice president, donor relations and marketing, ImpactLife, to better understand the importance of this annual day of hope and giving.

Advancing Blood Cancer Care Through Communication and Personalized Treatment

Jun 12, 2025

Patient care increasingly relies on clear communication, interdisciplinary support, personalized treatment strategies based on diagnostic insights.

UC Remission Doesn’t Boost Patient Satisfaction

Jun 12, 2025

Despite treatment, a significant proportion of patients with ulcerative colitis continue to experience moderate-to-severe symptoms that impact quality of life.

PsA Experts Share NSAID Prescribing Best Practices

Jun 12, 2025

Recent recommendations include short-term, tailored NSAID use for PsA symptom relief while favoring on-demand use and caution in patients with other risks.

Terms and Conditions – Oncology Clinical Trial Survey

Jun 5, 2025

Many patients miss out on clinical trials, and we’d like to understand why. Oncology Clinical Trial Survey Official Rules All survey participants will receive a $25 gift card—no purchase of any goods are necessary to...

Shifting GCA Management Toward Targeted Therapies by Minimizing Glucocorticoid Toxicity

Jun 4, 2025

Newer steroid-sparing therapies, such as IL-6 inhibitors and selective JAK1 inhibitors like upadacitinib (Rinvoq), have shown promise in improving remission rates while reducing adverse effects.

Mohs Surgery Demonstrates Improved Outcomes in SCC

Jun 3, 2025

In patients with cutaneous squamous cell carcinoma, Mohs surgery was associated with significantly better outcomes compared with wide local excision.

Web-Based Intervention Improves Emotional and Physical Health in Adults With Fibromyalgia

Jun 3, 2025

An internet-delivered positive affect intervention showed initial success in improving emotional well-being, reducing pain and fatigue, and enhancing response to daily positive events in adults with fibromyalgia.

Key Predictors of Remission, Relapse in IgG4-Related Ophthalmic Disease Revealed

Jun 3, 2025

A large multicenter study found that surgical debulking and steroid tolerability significantly improved remission in IgG4-related ophthalmic disease.

The Role of Ultrasound in Diagnosing Tardive Dyskinesia: A New Frontier in Movement Disorders

Jun 3, 2025

The emerging use of ultrasound in TD offers a promising, noninvasive tool for earlier detection, targeted treatment, and improved patient outcomes.

A Physician’s Role in Guiding Severe COPD Patients Toward Advanced Treatments

Jun 2, 2025

Severe emphysema is a progressive, debilitating disease that quietly erodes patients’ quality of life, but emerging treatments like bronchoscopic lung volume reduction offer hope for restoring function and independence in carefully selected individuals.

Gene Therapy Reverses Peripheral Neuropathy Progression in Pre-Symptomatic LI-MLD Patients

Jun 2, 2025

Findings of a recent post-hoc analysis, which was presented at PNS 2025, demonstrated the efficacy of a gene therapy in reducing the severity and progression of peripheral neuropathy.

Breast Cancer Targeted Therapies and Guidelines, Part 2

Jun 2, 2025

Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the treatment landscape across HR-positive, HER2-positive, and triple-negative subtypes.

Green Urine: Is This a UTI?

Jun 2, 2025

A 50-year-old male Ukrainian patient, with paraplegia due to a transverse spinal cord injury after a gunshot, was admitted to the emergency department with green urine.

PW Trivia: A Common Precursor Lesion in SCC

Jun 2, 2025

Identifying precursor lesions is key to early intervention—one in particular is most commonly associated with the development of squamous cell carcinoma.

PW Trivia: Cryptosporidium Infections

Jun 2, 2025

Cryptosporidium infections can vary by immune status—but in healthy individuals, one symptom tends...

PW Trivia: The Primary Cause of Hyperparathyroidism

Jun 2, 2025

Understanding the root cause of elevated calcium levels starts with knowing the most common culprit behind primary hyperparathyroidism.

PW Trivia: Targeting IL-6 in Rheumatoid Arthritis

May 30, 2025

Targeting specific cytokines is key in rheumatoid arthritis treatment—see if you know which biologic agent focuses on interleukin-6.

Screening Tools Help Identify Fear of Recurrence in Cancer Survivors, Part 4

May 15, 2025

Shelley Johns, PsyD, joins Physician’s Weekly, for one final installment. She emphasizes the importance of standardized screening for fear of recurrence in breast cancer survivors.

Follow Us

Author: Julie Gould